Trial Profile
A Double-Blind Sequential Parallel Study of Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2019
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Bipolar depression; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 12 Aug 2019 Planned initiation date changed from 1 Jan 2019 to 1 Sep 2019.
- 12 Dec 2018 New trial record